Having bought some at 12.5 and then averaging down big time around 8, I wasn't sure what would happen. Glad there was a validation from a big pharma. Now, only if BDSI would do the same thing. Lol
My point is that Aratana could have conducted the same trial long time ago. For some reason, they did not; and no one is asking them why they didn't.
Sentiment: Strong Buy